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Introduction
Diabetes mellitus is an epidemic disease worldwide, characterized by plasma glucose concentrations mostly remaining above the normal range. Depending on the pathogenic mechanisms involved, diabetes is classified into two main categories: type 1 and type 2 diabetes. Type 1 diabetes is generally due to the immune system of the patients destroying β cells in the islets of Langerhans of the pancreas and thus preventing production and secretion of insulin. Type 2 diabetes is mainly due to dysfunction of the glucose-insulin regulatory system [1, 2] . Since the discovery of diabetes, many researchers have attempted to find out how the endocrine metabolic system works [3, 4] and why there are dysfunctions [5] in order to devise effective and efficient therapies to improve the daily life of diabetic patients.
In insulin therapies, the subcutaneous injection of insulin or its analogues by using an insulin pump when needed is a typical treatment. This not only provides a basic treatment for type 1 diabetes [6] , but also supplies a viable alternative for type 2 diabetes although the latter can be controlled, or even cured, by life-style changes such as dietary adjustment, physical exercise, stopping smoking and avoiding exposure to second-hand smoke [7, 8, 9] . Due to technological difficulties, the main obstacle in insulin therapies, however, is difficulty in the monitoring of plasma glucose concentrations non-invasively. Thus, all current therapies are open-loop treatments that are unable to use the feedback of glucose concentration automatically [10] . When an accurate non-invasive glucose monitoring technique is developed, the open-loop treatment could be replaced by closed-loop therapy, with an artificial pancreas delivering insulin automatically according to variations in blood glucose levels [10, 11, 12 ].
An artificial pancreas, which is still being developed would function like a real and healthy pancreas allowing diabetic patients to control their blood glucose levels within a normal range automatically [13] . With the help of such an artificial pancreas, patients could improve their life-styles without injecting insulin manually or measuring the glucose infusion rate. However, there are two major impediments to the development of an artificial pancreas including the need for reliable predictive models and the lack of effective and efficient control algorithms [12, 13] . To overcome these problems, several reliable mathematical models of delay differential equations which can de-termine the time and the dose of insulin injections for control algorithms have been proposed and investigated [14, 15, 16] . Moreover, pulsatile insulin secretion has been employed to mimic impulsive injections for type 1 or type 2 diabetes mellitus treatment regimes [15, 16] . Recently, Huang et al. devised a new mathematical model with open-loop control considering impulsive injection of insulin either periodically or by monitoring the plasma glucose concentration level [13] . The model can be described by
G(t + ) = G(t), I(t + ) = I(t) + σ,
where G(t) is the glucose concentration at time t, I(t) is the insulin concentration at time t, G in is the estimated average constant rate of glucose input, σ 2 indicates the insulin-independent glucose uptake rate, the term
aG(t)(c + mI(t)/(n + I(t))
) stands for the insulin-dependent glucose utilization, b represents the hepatic glucose production, σ 1 G 2 (t)/(α 2 1 + G 2 (t)) is insulin secretion stimulated by elevated glucose concentration caused by complex pathways including chemical-electrical processes, d indicates the insulin degradation rate. In addition, all parameters are positive (for details see [13] ), with initial condition G(0) = G 0 > 0, I(0) = I 0 > 0. τ is the period of the impulsive injection of insulin, σ denotes the dose of insulin in each injection applied as an impulse at discrete times t = hτ, h ∈ Z + = {1, 2, 3, ...}. Note that insulin pumps with an open-loop approach have made significant contributions to insulin clinical therapies. However, open-loop therapy changes the life-styles of the patients and increases their likelihoods of becoming hyperinsulinaemic or hyperglycaemic. For example, a patient has to inject insulin at a fixed time without monitoring the plasma glucose concentrations automatically. So the following questions arise: what is an ideal treatment for diabetes patients and how does it work? From both practical and theoretical points of view, the most effective insulin therapy for diabetes patients is to control their blood glucose levels within a desirable range, once the blood glucose reaches a critical glucose threshold (CGT) instead of periodic injections of insulin. Meanwhile, when the blood glucose level is below the critical glucose threshold, diabetes patients can take up glucose normally, as shown in Fig. 1 .
The critical glucose threshold can be defined as the glucose level in the blood when insulin injections must be taken to prevent the dangerous glucose level (DGL) from being reached and exceeded, where the DGL is the blood glucose level that will cause harm to patients. For example, insulin injections must be taken once the critical concentration of glucose is observed by a glucose monitoring system so that the DGL cannot be exceeded, i.e., sufficient lead time is needed between the time when the critical concentration of glucose is observed and the time when a treatment is applied (obviously, CGT is less than DGL). Then it is revealed that the most reasonable treatment is when insulin is injected automatically in a closed-loop technique integrated with the glucose monitoring system.
A blood glucose level within the normal range is needed for human body organs to play their roles in maintaining relevant biological activities. Otherwise, hyperglycaemia induces glucotoxicity, while hypoglycaemia suppresses normal functioning of the organs [17] . For these reasons, the patients must initiate insulin therapy once the blood glucose level has climbed above an upper threshold (denoted by G T H , G T H ≤ 120mg/dl) and suspend it once the blood glucose level dips below a lower threshold (denoted by
T H ] is called a threshold window of treatment decision [18] . In this case, we can extend model (1.1) by replacing the impulsive injection of insulin by lower and upper thresholds, which can be written as the following two states.
Glucose infusion state
Where all parameters are the same as those in model ( Moreover, when the lower threshold G T H is equal to the upper threshold
, then this corresponds to a special case for models (1.2) and (1.3) with a single threshold. In this case the models (1.2) and (1.3) can be rewritten as a Filippov system, a model which has been applied widely in many fields of science and engineering. Furthermore, the theory of Filippov systems is being recognized as not only richer than the corresponding theory of continuous systems, but also as representing a more natural framework for the mathematical modelling of real-world phenomena [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] .
The paper is arranged as follows. In section 2, the global dynamics of models (1.2) and (1.3) with a single threshold are studied in detail: the existence and stability of several types of equilibria are discussed and the relations between the existence of a regular equilibrium and a pseudo-equilibrium are also discussed. Meanwhile, by using qualitative analysis techniques of nonsmooth Filippov dynamic systems the sufficient and necessary conditions for the global stability of regular points and a pseudo-equilibrium are provided, and then sliding bifurcations related to boundary node bifurcations are investigated by employing theoretical and numerical techniques. Furthermore, in section 3, using our proposed piecewise dynamic models with a threshold window we will explore the effects of glucose thresholds or the widths of threshold windows on the durations of insulin therapy and glucose infusion processes (i.e., the number of switches between the insulin injection state and the glucose infusion state). 2) and (1.3) If G < G C , then the qualitative behaviour of system (1.2) is determined by the following subsystem:
where we denote ξ = σ 2 + ac throughout the paper. For σ 1 ≥ 0, there exists an unique positive equilibrium E 1 (G 1 , I 1 ) of system (2.1) with G 1 > 0 and I 1 > 0. The linearized system of (2.1) at the equilibrium E 1 (G 1 , I 1 ) is as follows:
where 
Therefore, according to the Bendixson theorem, no closed orbit for system (2.1) exists, which implies that E 1 is globally asymptotically stable. If G > G C , the qualitative behaviour of system (1.3) is guaranteed by the following subsystem
Similarly, there exists an unique equilibrium E 2 (G 2 , I 2 ) of system (2.2) with G 2 > 0 and I 2 > 0, and E 2 is globally asymptotically stable. Lemma 2.1. E 1 of system (2.1) and E 2 of system (2.2) are both globally asymptotically stable.
Existence of sliding segment
Let
then systems (1.2) and (1.3) can be written as the following Filippov system
where
T |G ≥ 0, I ≥ 0}. Furthermore, the discontinuity boundary (or manifold) Σ separating the two regions S 1 and S 2 is described as Σ = {Z ∈ R 2 + |H(Z) = 0}. From now on, we call Filippov system (2.3) defined in region S 1 and S 2 as system S 1 and S 2 , respectively.
where ⟨·⟩ denotes the standard scalar product. Then the interior of the sliding mode domain can be defined as [26, 31, 32] 
According to the definition of σ(Z), we have
solving the inequality σ(Z) < 0 yields
Therefore, the sliding segment of Filippov system (2.3) can be defined as
Sliding mode dynamics and existence of the equilibria
The following definitions of all types of equilibria of Filippov system (2.3) are necessary throughout the paper [19, 26, 31, 32] .
. The dynamics on the sliding mode Σ S can be obtained by using Utkin ′ s equivalent control method [33] , i.e. we have
There may be four types of equilibria for Filippov system (2.3): regular equilibrium (denoted as E R ), virtual equilibrium (denoted as E V ), pseudoequilibrium (denoted as E P ) and boundary equilibrium (denoted as E B ), while the tangent point is denoted as E T . From the analysis of section 2.1, we have the following results.
We can see that G 1 > G 2 must hold. Let I 1 and I 2 be an arbitrarily constant I d , and substitute it into the first equation of models (2.1) and (2.2), thus
R and E 2 becomes a virtual equilibrium denoted by E 2 V . Now we investigate the pseudo-equilibrium of the system (2.3). Solving ϕ(I) = 0, we get the following equation
we get a unique positive root denoted by I P = (−A + √ ∆)/2dG in . Therefore, there is an unique positive pseudo-equilibrium
The tangent points of Σ S satisfy G = G C and
Then there are two tangent points denoted as
The boundary equilibrium of Filippov system (2.3) satisfies G = G C , equations (2.1) and (2.2), then the boundary equilibrium of system (2.3) is obtained as follows
) .
Lemma 2.2. The two virtual equilibria E 1
V and E 2 V , and the pseudoequilibrium E P can coexist in Filippov system (2.3). Further, the pseudoequilibrium E P is stable in the sliding domain Σ S . Proof. When I P ∈ (I c2 , I c1 ), i.e.
This inequality is equivalent to the conditions for the coexistence of two virtual equilibria E 1 V and E 2 V . In order to prove that E P is stable in the sliding domain, we only need to prove that the inequality ϕ ′ (I P ) < 0. By simple calculation we get
therefore, E P is stable. The proof is complete. Now we investigate the global dynamic behaviour of the Filippov system (2.3).
Global qualitative analysis of Filippov system (2.3)
Based on the subsection 2. 
The proofs of Theorems 2.3, 2.4 and 2.5 are provided in Appendix A, Appendix B and Appendix C, respectively. Remark. Based on the above analyses, it is known that for the Filippov system (2.3) there exist globally asymptotically stable equilibria E 1 or E 2 or a pseudo-equilibrium E P under certain conditions. From a biological viewpoint, it indicates that with different values of the threshold the blood glucose and the insulin concentrations may stabilize at different fixed levels represented by E 1 , E 2 and E P . This suggests that the threshold G C can be selected as a basis to control the blood glucose concentration at a desired level within the normal range.
Note that the main results would play a key role in determining the threshold conditions, which guarantee that the blood glucose level is maintained within a normal range. In the coming section, we will investigate the bifurcation analysis and biological implications of model (2.3) for type 2 diabetes, both theoretically and numerically.
Bifurcation analysis and biological implications of Filippov system (2.3) for type 2 diabetes
In insulin therapies, the use of an insulin pump provides the basic treatment for diabetes [7, 8, 9] . In section 2.4, the dynamical behaviour of Filippov system (2.3) has been investigated in detail. In this section, we address the biological implications of our main results by using bifurcation analysis.
The parameter values for models (1.2) and (1.3) (provided in Table 1 ) used in our simulations were either determined by previous research [3, 4, 13, 34, 35] , or obtained from models for the intravenous glucose tolerance test (IVGTT) [35] [36] [37] . We converted units as appropriate and adjusted the values to be within reasonable ranges.
Firstly, the bifurcation set of equilibria and sliding mode will be investigated. We address the richness of the possible equilibria and sliding modes that Filippov system (2.3) can exhibit; we chose parameters b and G C to build the bifurcation diagram and fixed all other parameters as those in Table 1 . Then we can define lines for parameters b and G C as follows: Fig.2 ). It is clear that bifurcations can occur when one of the parameters, such as G C , varies, which we will address in more detail below.
A boundary node bifurcation for system (2.3) may occur once the equilibria E 2 R , E 2 T and E 2 B collide together simultaneously when G C passes through a critical value [19, 26] . Choosing the parameter G C = 39.18mg/dl, then the regular equilibrium E 2 R , the visible tangent point E 2 T and the boundary equilibrium E 2 B can collide together at E 2 B , as shown in Fig.3(b) , where G C can be obtained by G C = b(n+I 2 )/((am+ξ)I 2 +ξn), and this boundary equilibrium E 2 B is an attractor with an incoming stable sliding orbit. This implies that the blood glucose and the insulin concentration can stabilize at a fixed level Fig.3(a) ). In this case, injection of insulin controls the blood glucose level at a low level (less than 60mg/dl) leading to hypoglycaemia, which suppresses normal functioning of the body's organs. In addition,
and are substituted by a stable pseudo-equilibrium E P and an invisible tan- Fig.4(a) with G C = 100mg/dl. This means that the blood glucose level stabilizes at the pseudo-equilibrium (100mg/dl), which indicates that the blood glucose level could be successfully maintained at a desired level within the normal range. Besides, this bifurcation shows how a stable node becomes a stable pseudo-equilibrium.
Moreover, another boundary node bifurcation for system (2.3) occurs at G C = 130.32mg/dl (Fig.4) , where G C is obtained by
In this case the boundary equilibrium E 1 B is stable (Fig.4(b) ). The virtual equilibrium E 1 V , the virtual equilibrium E 2 V , the invisible tangent point E
1
T and E 2 T and the stable pseudo-equilibrium E P coexist when b(n + I 2 )/((am + ξ)I 2 + ξn) < G C < (G in + b)(n + I 1 )/((am + ξ)I 1 + ξn) with G C = 100mg/dl (see Fig.4(a) ). Further, they collide at
, there is only a stable regular equilibrium E 1 R and part of the sliding domain Σ S , as shown in Fig.4(c) . This implies that the patient will be free from insulin therapy, and the blood glucose stabilizes at a high level (large than 120mg/dl) which leads to hyperglycaemia and glucotoxicity. Therefore, it suggests that the threshold G C should be carefully chosen by medical workers to maintain the blood glucose level at a desired level. It is manifest that this bifurcation indicates how a stable pseudo-equilibrium becomes a stable node.
From the bifurcation analysis, we can choose the threshold level G C ( for example, G C = 100mg/dl which belongs to the normal range) such that all equilibria of each subsystem such as system S 1 and system S 2 become virtual, and the pseudo-equilibrium lying in the sliding mode domain is globally stable. This not only can prevent the possibility of hypoglycaemia and hyperglycaemia, but also constrains the blood glucose level to stabilize at a desired level by insulin therapy. These results clarify that the model (2.3) for type 2 diabetes proposed here can provide reliable predictive outcomes to model the regulatory system for diabetes. Similar results can be obtained for type 1 diabetes (not shown here).
Investigations of insulin therapy with a threshold window
The insulin therapy with a single threshold indicates that the blood glucose can be controlled at a desired level within the normal range. Now, we focus on piecewise glucose-insulin systems (1.2) and (1.3) with two threshold values, or with a threshold window, which are proposed for modelling the regulatory system for diabetes. In particular, as discussed in the introduction, insulin therapy with a threshold window allows a patient to continue the injection of insulin until his/her blood glucose level drops down to the lower threshold value G T H , then suspend the therapy; the insulin therapy is only re-started when the blood glucose level goes over the upper threshold value G T H . It would be interesting to investigate how the threshold window governs the durations of insulin therapy and glucose infusion and dynamics of the blood glucose level, in addition to clinical outcomes. We use the proposed models (1.2) and (1.3) for these purposes. In order to avoid redundancy, we mainly focused on type 2 diabetes.
For type 2 diabetes, based on models (1.2) and (1.3), we have G 1 > G 2 . Generally we assume that G 1 > G T H and G 2 < G T H . Then according to relationships among G 1 , G 2 , the lower threshold value G T H and the upper threshold value G T H , we have the following possible cases:
For Case 1, we can easily see that both equilibria E 1 and E 2 are virtual (see Fig.5(b) ). It is clear that virtual equilibria can never be actually attained. For example, a trajectory starting, say, in S 2 never approaches a stable virtual equilibrium E 2 and reverts to the glucose infusion state as soon as it crosses the lower threshold G T H , while a trajectory starting in S 1 never approaches a stable virtual equilibrium E 1 and reverts to the insulin injection state immediately when it crosses the upper threshold G T H . Combining these two observations, we find that the system may switch between the glucose infusion state (1.2) and the insulin injection state (1.3) forever. Fix all parameter values as those listed in Table 1 . Simple calculations give G 1 = 130.32mg/dl and G 2 = 39.18mg/dl. Choosing G T H = 65mg/dl and G T H = 115mg/dl within the normal range, Fig.5(a) shows that, for the given threshold window, the blood glucose level fluctuates periodically during the whole medical process. The durations of insulin injections and glucose infusions are shown in Fig.5(c) , which suggests that the durations of each insulin injection and glucose infusion are stabilized at fixed values and the stable duration of glucose infusion is larger than the duration of insulin injection. In particular, we can obtain how fast the blood glucose level rebounds to the upper threshold value G T H for type 1 diabetes (see Appendix D). In order to further show the effect of a threshold window on the durations or number of insulin injections and glucose infusions switches for Case 1, we consider the following different settings for threshold windows (as shown in Fig.6 ). First, we fixed the width of the threshold window such that G T H − G T H = 30mg/dl, and let the lower threshold value G T H increase from 60 to 90mg/dl, where G T H = 60 + 1.5(n − 1) for n = 1, 2, ..., 21 (see Fig.6(a) and Fig.6(b) ). For the same width of threshold window, it is interesting to note that as G T H increases, the duration of glucose infusion decreases (Fig. 6(b) ) while the duration of insulin injection increases (Fig.6(a) ). This indicates that, for the same width of threshold window, the larger the lower threshold value G T H , the more the time needed for the blood glucose level to fall down to the lower threshold and the less the time needed for the blood glucose level to rebound to the upper threshold. Secondly, we fixed the upper threshold value G T H = 120mg/dl, and let the lower threshold value G T H vary from 60 to 90mg/dl with G T H = 60 + 1.5(n − 1) for n = 1, 2, ..., 21 (see Fig.6 (c) and Fig.6(d) ). It follows that, as G T H increases (and consequently as the threshold window becomes narrower), it takes more time for the blood glucose level to fall down or rebound, as shown in Fig.6(c) . Finally, we fixed the lower threshold value G T H = 60mg/dl, and let the upper threshold value G T H increase from 75 to 105mg/dl with G T H = 75 + 1.5(n − 1) for n = 1, 2, ..., 21 (see Fig.6 (e) and Fig.6(f) ). It is seen that, as G T H increases (and consequently as the threshold window becomes wider), the duration of the insulin injection monotonically increases whilst the duration of the glucose infusion decreases, and it is observed that the blood glucose level took more and more time to come down. It follows from Fig.6(a) and Fig.6 (e) that, as the upper threshold G T H increases, the duration of insulin injection monotonically increases. So an issue is arising whether there is a certain value of the upper threshold value G T H above which the insulin injection state with a threshold window cannot maintain the periodical fluctuation of the blood glucose level. Thus, could the normal range of the blood glucose level be maintained by using insulin therapy? To answer this question, we focus our discussion on Cases 2 − 4 below.
For Case 2, the equilibrium E 1 becomes a regular steady state, which is globally stable for system (1.2) only. It is interesting to examine for the whole systems (1.2) and (1.3) how the blood glucose level behaves. It follows from Fig.7(a) and Fig.7 (b) that any trajectory initiating from region S 1 or S 2 approaches the regular equilibrium E 1 for G T H = 65mg/dl and G T H = 140mg/dl. It indicates that for a patient with an upper threshold for stopping injecting insulin, it may result in a constant blood glucose level without insulin therapy, which is dangerous for diabetes patients. For Case 3, we have that both equilibria E 1 and E 2 are regular and globally stable for their own systems. Fig.7(c) and Fig.7(d) show that the blood glucose level will approach certain levels represented by the equilibria E 1 and E 2 , corresponding to a continuous treatment strategy (the insulin injection state) and free from insulin therapy (the glucose infusion state), under thresholds G T H = 30mg/dl and G T H = 140mg/dl (details see Fig.7 (c) and Fig.7(d) ). This suggests that the blood glucose level may be maintained at different fixed levels depending on the patient's initial blood glucose level. For Case 4, we have the virtual equilibrium E 1 and the regular equilibrium E 2 , which is globally stable for system (1.3) only. Similarly to Case 2, the blood glucose level approaches a certain value corresponding to the insulin therapy, as shown in Fig. 7(e) and Fig.7(f) .
Conclusion
Since the pioneering work on the dynamics of plasma insulin concentrations that led to the glucose-insulin regulatory system contributing to insulin therapies, a number of research papers have appeared on the topic [2, 3, 10, 13, 15, 16, 39, 40] . Numerous studies have focused on the glucoseinsulin regulatory system via a mathematical model of delay differential equations. Recently, Huang et al. proposed two novel mathematical models with impulsive injections of insulin or its analogues for type 1 and type 2 diabetes mellitus [13] , and similar impulsive differential equations have been widely used in integrated pest management [28, 29, 41, 42] . In their paper, Huang et al. assumed that the constant glucose infusion rate G in is described by a continuous process and insulin is injected once the blood glucose level reaches a threshold or at a fixed time. However, in clinical insulin therapies, the most satisfactory treatment would be: if the blood glucose level falls below a critical threshold, then injection of insulin is not applied and the patients can take up glucose with constant rate G in ; if the blood glucose level increases and exceeds a critical threshold, then insulin is injected with dose σ automatically and the glucose infusions are suspended. This regime is worked as a closed-loop technique which is integrated with a glucose monitoring system. Therefore, in this paper, we proposed piecewise glucose-insulin dynamic models with threshold windows, which extended the dynamic model (1.1). Hence the models formulated here can better describe the effect of insulin therapy on the blood glucose level.
The dynamics of models (1.2) and (1.3) with a single threshold were investigated. In particular, the sufficient and necessary conditions for the globally stable regular equilibrium and pseudo-equilibrium are provided by using qualitative analysis techniques of non-smooth Filippov dynamic systems. Furthermore, sliding bifurcations with respect to boundary node bifurcations have been studied by employing theoretical and numerical techniques. The results indicate that when choosing the single threshold G C as a control parameter, the concentrations of glucose and insulin always stabilize at a regular equilibrium or a pseudo-equilibrium. However, in insulin therapies, to prevent the risk of hyperglycaemia or hypoglycaemia, it is critical to choose a desirable threshold level (here G C ) such that all equilibria of each system such as system S 1 and system S 2 become virtual, and the pseudo-equilibrium which is lying in the sliding mode domain is globally stable, then the blood glucose level can be controlled at a prescribed level within the normal range.
In addition, the dynamical behaviour of models (1.2) and (1.3) for type 2 diabetes with a threshold window were investigated numerically (for type 1 diabetes, the results are similar so we omitted them). We have studied several different scenarios based on the relations between the thresholds and equilibria using the proposed models (1.2) and (1.3). Our results show that the blood glucose level can either fluctuate around the two prescribed thresholds or stabilize at an equilibrium for the insulin injection or glucose infusion state. In particular, for a patient with a fixed blood glucose level at the treatment starting time, it requires insulin injection and glucose infusion switches in a treatment regime to maintain the blood glucose level within the normal range for choosing an appropriate threshold window (for example 65 − 115mg/dl, see Fig.5 ). In contrast, if the upper threshold value is larger or the lower threshold value is smaller than the lower value of a normal range which corresponds to Case 2, 3 and 4 in section 3, the threshold window cannot maintain the periodical fluctuation of the blood glucose level. This indicates that the blood glucose level will approach certain levels represented by the equilibrium E 1 or E 2 , corresponding to a continuous treatment strategy (the insulin injection state) or free from insulin therapy (the glucose infusion state), both of which increase the risk of hyperglycaemia or hypoglycaemia. Furthermore, insulin therapy is needed for a patient with a relatively high blood glucose level, while glucose infusion is required to maintain the blood glucose level above a safe level. This further confirms that it is important to individualize the treatment strategy for different patients with different initial blood glucose levels. Moreover, we have also shown (see Fig.6 ) that the effects of the thresholds and the widths of the threshold windows on the durations of insulin injection states and glucose infusion states are complex. The duration of the insulin injection state is more sensitive to the variation of thresholds compared to that of the glucose infusion state, for details see Fig.6 (a) and Fig.6(e) .
Note that the insulin degradation rate is assumed to be proportional to the insulin concentration, but it is more realistic to assume that the insulin degradation rate obeys Michaelis-Menten kinetics [16] . Moreover, the effect of physical exercise on the dynamics of glucose and insulin has been investigated [43] , thus it would be interesting to know how this might affect the dynamics if we included it in our proposed models. Consequently, we plan to address these topics with the aim of improving optimal strategies for the treatment of diabetes in the near future, studies that will be reported elsewhere. (Fig.4(a) ). Now we prove the global stability of the pseudo-equilibrium E P of Filippov system (2.3).
First, all trajectories starting from region S 1 and S 2 which meet the sliding domain Σ S will tend to the pseudo-equilibrium E P according to Lemma 2.2. Second, all other trajectories will finally reach the sliding domain Σ S and converge to the pseudo-equilibrium E P . Otherwise, there must be some solution initiating from region S 1 or S 2 tending to another equilibrium, a limit cycle or infinity. These results contradict the properties of vector fields and nonexistence of a limit cycle of region S 1 and S 2 . Therefore, the pseudoequilibrium E P of Filippov system (2.3) is globally asymptotically stable. Now we prove that G 2 ≤ G C ≤ G 1 are necessary conditions for the stability of the pseudo-equilibrium E P . We first prove G C ≥ G 2 . Otherwise, the condition G C < G 2 ensures the stability of the regular equilibrium E 2 of Filippov system (2.3). Next we show that G C ≤ G 1 must hold true. Otherwise, if G C > G 1 , then E 1 becomes a regular equilibrium, and consequently the pseudo-equilibrium E P does not exist according to Lemma 2.2. This contradicts the global stability of the pseudo-equilibrium E P . Thus we have
The proof is complete.
Appendix C: The proof of Theorem 2.5
If G C > G 1 , then E 1 becomes a regular equilibrium and E 2 is a virtual equilibrium. From Lemma 2.2, the pseudo-equilibrium E P does not exist (Fig.4(c) ). Further, part of the sliding domain Σ S is down below the x-axis. Therefore, to prove the globally asymptotically stable E 1 of Filippov system (2.3), we only need to show that all solutions initiating from region S 2 will meet the threshold line G C and enter into region S 1 . In fact, it is evident that all solutions starting from region S 2 meet the threshold line G C and then enter into region S 1 according to the properties of vector fields S 2 . Furthermore, all solutions initiating from region S 1 converge to the equilibrium E 1 . Then E 1 of Filippov system (2.3) is globally asymptotically stable. Now we show that G C > G 1 must hold true. Otherwise, if G C ≤ G 1 , then E 1 becomes a virtual equilibrium, and consequently the stable pseudoequilibrium E P exists or the stable E 2 exists. This contradicts the global stability of the equilibrium E 1 . This completes the proof.
Appendix D: The duration of the glucose infusion state
For type 1 diabetes, the duration of the glucose infusion state can be described as follows:
(4.1) We assume that the first time the blood glucose level drops and reaches the lower threshold value G T H is at time t 1 , i.e., we have T (t 1 ) = G T H . Note that the analytical solution of the second equation of the model (4.1) with initial values of T (t 1 ) can be obtained by direct integration, i.e.,
Substituting I(t 1 ) into the first equation of (4.1) for I(t), then integrating the first equation of (4.1) yields
suppose the blood glucose level went to the upper threshold G T H at time t 2 , i.e., we have T t 2 = G T H , then we have the following equation 
